SWOT Analysis for Dr. Reddy's Laboratories Ltd.

Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Companies with 10% increase in share price over three months, with rising net profit growth
Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
Upcoming results with Rising Delivery Volumes
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ

Upcoming results with Rising Delivery Volumes

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
PEG greater than Industry PEG
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Increasing Trend in Non-Core Income
RSI indicating price weakness
Top Losers

Companies with growing costs YoY for long term projects

PEG greater than Industry PEG

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Companies with Upcoming Results
Brokers upgraded recommendation or target price in the past three months
Highest FII stock holdings
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months

Companies with Upcoming Results

Brokers upgraded recommendation or target price in the past three months

Highest FII stock holdings

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Red Flags: Firms linked to ongoing regulatory investigations/legal cases
US FDA Warning Letter

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

US FDA Warning Letter

Stocks with improving cash flow, with good durability
Rising Delivery Percentage Compared to Prev Day
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Stocks with improving cash flow, with good durability

Rising Delivery Percentage Compared to Prev Day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Dr. Reddy's Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dr. Reddy's Laboratories Ltd. has 16 Strengths, 6 Weaknesses, 5 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with 10% increase in share price over three months, with rising net profit growth

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ

Upcoming results with Rising Delivery Volumes

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PEG greater than Industry PEG

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Companies with Upcoming Results

Brokers upgraded recommendation or target price in the past three months

Highest FII stock holdings

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

US FDA Warning Letter

Stocks with improving cash flow, with good durability

Rising Delivery Percentage Compared to Prev Day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks